Literature DB >> 8855328

Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.

T Ohshima1, J M Ward, C G Huh, G Longenecker, H C Pant, R O Brady, L J Martin, A B Kulkarni.   

Abstract

Although cyclin-dependent kinase 5 (Cdk5) is closely related to other cyclin-dependent kinases, its kinase activity is detected only in the postmitotic neurons. Cdk5 expression and kinase activity are correlated with the extent of differentiation of neuronal cells in developing brain. Cdk5 purified from nervous tissue phosphorylates neuronal cytoskeletal proteins including neurofilament proteins and microtubule-associated protein tau in vitro. These findings indicate that Cdk5 may have unique functions in neuronal cells, especially in the regulation of phosphorylation of cytoskeletal molecules. We report here generation of Cdk5(-/-) mice through gene targeting and their phenotypic analysis. Cdk5(-/-) mice exhibit unique lesions in the central nervous system associated with perinatal mortality. The brains of Cdk5(-/-) mice lack cortical laminar structure and cerebellar foliation. In addition, the large neurons in the brain stem and in the spinal cord show chromatolytic changes with accumulation of neurofilament immunoreactivity. These findings indicate that Cdk5 is an important molecule for brain development and neuronal differentiation and also suggest that Cdk5 may play critical roles in neuronal cytoskeleton structure and organization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855328      PMCID: PMC38303          DOI: 10.1073/pnas.93.20.11173

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  Posttranslational modification of neurofilament proteins by phosphate during axoplasmic transport in retinal ganglion cell neurons.

Authors:  R A Nixon; S E Lewis; C A Marotta
Journal:  J Neurosci       Date:  1987-04       Impact factor: 6.167

3.  Lewy bodies of Parkinson's disease contain neurofilament antigens.

Authors:  J E Goldman; S H Yen; F C Chiu; N S Peress
Journal:  Science       Date:  1983-09-09       Impact factor: 47.728

4.  Multiple phosphorylation sites in mammalian neurofilament polypeptides.

Authors:  J P Julien; W E Mushynski
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

5.  Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.

Authors:  L A Sternberger; N H Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Posttranslational modification of neurofilament polypeptides in rabbit retina.

Authors:  M A Glicksman; D Soppet; M B Willard
Journal:  J Neurobiol       Date:  1987-03

7.  Aluminum intoxication: a disorder of neurofilament transport in motor neurons.

Authors:  J C Troncoso; P N Hoffman; J W Griffin; K M Hess-Kozlow; D L Price
Journal:  Brain Res       Date:  1985-09-02       Impact factor: 3.252

8.  In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy.

Authors:  D G Graham; G Szakál-Quin; J W Priest; D C Anthony
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis.

Authors:  A Hirano; H Donnenfeld; S Sasaki; I Nakano
Journal:  J Neuropathol Exp Neurol       Date:  1984-09       Impact factor: 3.685

10.  Aluminum effect on slow axonal transport: a novel impairment of neurofilament transport.

Authors:  A Bizzi; R C Crane; L Autilio-Gambetti; P Gambetti
Journal:  J Neurosci       Date:  1984-03       Impact factor: 6.167

View more
  289 in total

Review 1.  Neuronal migration disorders in humans and in mouse models--an overview.

Authors:  A J Copp; B N Harding
Journal:  Epilepsy Res       Date:  1999-09       Impact factor: 3.045

2.  Telling tails.

Authors:  M B Kennedy; P Manzerra
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

3.  The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic.

Authors:  G Paglini; L Peris; J Diez-Guerra; S Quiroga; A Cáceres
Journal:  EMBO Rep       Date:  2001-11-21       Impact factor: 8.807

4.  Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation.

Authors:  B S Li; L Zhang; J Gu; N D Amin; H C Pant
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

5.  Lis1 reduction causes tangential migratory errors in mouse spinal cord.

Authors:  Katherine D Moore; Renee Chen; Marianne Cilluffo; Jeffrey A Golden; Patricia E Phelps
Journal:  J Comp Neurol       Date:  2012-04-15       Impact factor: 3.215

Review 6.  Molecular control of neuronal migration.

Authors:  Hwan Tae Park; Jane Wu; Yi Rao
Journal:  Bioessays       Date:  2002-09       Impact factor: 4.345

7.  Three-dimensional structural analysis reveals a Cdk5-mediated kinase cascade regulating hepatic biliary network branching in zebrafish.

Authors:  Manali Dimri; Cassandra Bilogan; Lain X Pierce; Gregory Naegele; Amit Vasanji; Isabel Gibson; Allyson McClendon; Kevin Tae; Takuya F Sakaguchi
Journal:  Development       Date:  2017-07-15       Impact factor: 6.868

8.  A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice.

Authors:  Varsha Shukla; Ya-Li Zheng; Santosh K Mishra; Niranjana D Amin; Joseph Steiner; Philip Grant; Sashi Kesavapany; Harish C Pant
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

9.  Physiological and morphological characterization of dentate granule cells in the p35 knock-out mouse hippocampus: evidence for an epileptic circuit.

Authors:  Leena S Patel; H Jürgen Wenzel; Philip A Schwartzkroin
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

10.  Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease.

Authors:  Patrice D Smith; Stephen J Crocker; Vernice Jackson-Lewis; Kelly L Jordan-Sciutto; Shawn Hayley; Matthew P Mount; Michael J O'Hare; Steven Callaghan; Ruth S Slack; Serge Przedborski; Hymie Anisman; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.